-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Chimeric Antigen Receptor (CAR) T cell therapy uses engineered T cells to treat certain types of cancer, and is often a challenging method to treat solid tumors
"CAR-T cells are usually like lone soldiers without backup
The first tool is an endogenous RNA, or RNA from the body's own cells, called RN7SL1
Using a mouse model, the researchers showed that this combined blow is provided for CAR-T cells to mobilize the body’s own immune system and prevent tumor recurrence, even if many cancer cells cannot be recognized and killed by CAR-T cells alone
In addition to helping recruit the body's natural immune system, studies have shown that RN7SL1 can also improve the function of CAR-T cells themselves
"Simultaneous use of CAR-T cells, enhanced endogenous T cell function and strategies against common inhibitory mechanisms may provide an effective combination method to improve solid tumor response," said co-lead author Carl H.